SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-311070
Filing Date
2022-12-22
Accepted
2022-12-22 16:31:01
Documents
16
Period of Report
2022-12-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d432372d8k.htm   iXBRL 8-K 34924
2 EX-2.1 d432372dex21.htm EX-2.1 360720
3 EX-10.1 d432372dex101.htm EX-10.1 187564
4 EX-10.2 d432372dex102.htm EX-10.2 160502
5 EX-99.1 d432372dex991.htm EX-99.1 34548
  Complete submission text file 0001193125-22-311070.txt   1074520

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cprx-20221217.xsd EX-101.SCH 2872
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20221217_lab.xml EX-101.LAB 17995
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20221217_pre.xml EX-101.PRE 11276
10 EXTRACTED XBRL INSTANCE DOCUMENT d432372d8k_htm.xml XML 3335
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 221482321
SIC: 2834 Pharmaceutical Preparations